INST OF VIROLOGY OF THE SLOVAK has a total of 13 patent applications. Its first patent ever was published in 1999. It filed its patents most often in United States and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are INSERM (INSTITUT NAT DE LA SANTÉ ET DE LA RECH MÉDICALE), Ruprecht-Karls-Universität Heidelberg and INT INST CANCER IMMUNOLOGY INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Measuring microorganism processes | |
#5 | Medical preparations | |
#6 | Heterocyclic compounds | |
#7 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Pastorekova Silvia | 12 |
#2 | Pastorek Jaromir | 12 |
#3 | Scozzafava Andrea | 6 |
#4 | Zavada Jan | 6 |
#5 | Supuran Claudiu | 6 |
#6 | Gut Marta Ortova | 2 |
#7 | Zatovicova Miriam | 2 |
#8 | Zavadova Zuzanna | 2 |
#9 | Ebert Matthias | 1 |
#10 | Soyupak Buelent | 1 |
Publication | Filing date | Title |
---|---|---|
US2006057068A1 | CA IX-specific inhibitors | |
US7713704B1 | MN gene and protein | |
AU1132300A | MN gene and protein |